10,927
Total Claims
$1.2M
Drug Cost
1,088
Beneficiaries
$1,063
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-10%
Cost per patient vs peers
$1,063 vs $1,174 avg
+8%
Brand preference vs peers
9.6% vs 8.9% avg
Brand vs Generic
90% generic
Brand: 1,049 claims · $941K
Generic: 9,878 claims · $216K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 322 | $337K |
| Rivaroxaban | 185 | $215K |
| Sacubitril/Valsartan | 149 | $164K |
| Ticagrelor | 88 | $77K |
| Evolocumab | 68 | $50K |
| Ranolazine | 252 | $44K |
| Dronedarone Hcl | 24 | $37K |
| Alirocumab | 20 | $16K |
| Isosorbide Mononitrate | 685 | $12K |
| Metoprolol Succinate | 662 | $12K |
| Potassium Chloride | 215 | $8,753 |
| Atorvastatin Calcium | 618 | $7,675 |
| Rosuvastatin Calcium | 529 | $7,154 |
| Diltiazem Hcl | 215 | $6,725 |
| Nifedipine | 147 | $6,718 |
Prescribing Profile
70
Unique Drugs
$716K
Patient Profile
72
Avg Age
54%
Female
1.44
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About